Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORIMUNO-CORIPLASM: Convalescent Plasma in COVID-19
NCT04345991Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04345991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345991.